• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经前烦躁障碍中的肾上腺素能受体:I. 血小板α2受体:Gi蛋白偶联、月经周期阶段及黄体期症状严重程度的预测

Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.

作者信息

Gurguis G N, Yonkers K A, Phan S P, Blakeley J E, Williams A, Rush A J

机构信息

Laboratory of Clinical Neuroscience, Department of Veterans Affairs Medical Center, Dallas, TX 75216, USA.

出版信息

Biol Psychiatry. 1998 Oct 1;44(7):600-9. doi: 10.1016/s0006-3223(98)00097-3.

DOI:10.1016/s0006-3223(98)00097-3
PMID:9787884
Abstract

BACKGROUND

Abnormal alpha 2-adrenergic receptor (AR) function is implicated in anxiety and depressive disorders. Premenstrual dysphoric disorder (PMDD) is characterized by anxiety and depressive symptoms, which may be associated with changes in alpha 2AR function. Previous studies on alpha 2AR function during phases of the menstrual cycle in controls and PMDD patients are inconsistent.

METHODS

alpha 2AR function was examined in 16 PMDD patients and 15 controls during the follicular phase, and in 10 PMDD patients during late luteal phase. Antagonist-measured maximum binding capacity, agonist-measured receptor density in high- and low-conformational states, and agonist affinity to both states were measured. Coupling efficiency to Gi protein was estimated.

RESULTS

There were no significant differences in coupling efficiency. PMDD patients had significantly low antagonist affinity; there were no differences in other binding parameters. There were no changes in alpha 2AR binding parameters between phases of menstrual cycle in PMDD women. alpha 2AR density and symptom severity were inversely related during the follicular phase in controls and patients. During luteal phase, alpha 2AR density correlated positively with symptom severity in patients. High follicular alpha 2AR density predicted more severe luteal symptoms in PMDD patients.

CONCLUSIONS

These findings are discussed in view of the molecular biology of alpha 2AR, and their role in PMDD, anxiety, and depressive disorders.

摘要

背景

α2 - 肾上腺素能受体(AR)功能异常与焦虑症和抑郁症有关。经前烦躁障碍(PMDD)的特征是焦虑和抑郁症状,这可能与α2AR功能的变化有关。先前关于对照组和PMDD患者月经周期各阶段α2AR功能的研究结果并不一致。

方法

在卵泡期对16例PMDD患者和15例对照进行α2AR功能检测,在黄体晚期对10例PMDD患者进行检测。测量拮抗剂测定的最大结合容量、激动剂测定的高构象和低构象状态下的受体密度以及激动剂对两种状态的亲和力。估计与Gi蛋白的偶联效率。

结果

偶联效率无显著差异。PMDD患者的拮抗剂亲和力显著降低;其他结合参数无差异。PMDD女性月经周期各阶段之间α2AR结合参数无变化。在对照组和患者的卵泡期,α2AR密度与症状严重程度呈负相关。在黄体期,患者的α2AR密度与症状严重程度呈正相关。卵泡期α2AR密度高预示着PMDD患者黄体期症状更严重。

结论

鉴于α2AR的分子生物学及其在PMDD、焦虑症和抑郁症中的作用,对这些发现进行了讨论。

相似文献

1
Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.经前烦躁障碍中的肾上腺素能受体:I. 血小板α2受体:Gi蛋白偶联、月经周期阶段及黄体期症状严重程度的预测
Biol Psychiatry. 1998 Oct 1;44(7):600-9. doi: 10.1016/s0006-3223(98)00097-3.
2
Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.经前烦躁障碍中的肾上腺素能受体。II. 中性粒细胞β2-肾上腺素能受体:Gs蛋白偶联、月经周期阶段及黄体期症状严重程度的预测
Psychiatry Res. 1998 Jun 2;79(1):31-42. doi: 10.1016/s0165-1781(98)00025-0.
3
Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects.经前烦躁障碍患者和正常对照受试者在月经周期及睡眠剥夺情况下的皮质醇昼夜节律。
Biol Psychiatry. 2000 Nov 1;48(9):920-31. doi: 10.1016/s0006-3223(00)00876-3.
4
Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.惊恐障碍中的肾上腺素能受体功能。I. 血小板α2受体:Gi蛋白偶联、丙咪嗪的作用及其与治疗结果的关系。
Neuropsychopharmacology. 1999 Feb;20(2):162-76. doi: 10.1016/S0893-133X(98)00062-1.
5
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).患有和未患有经前烦躁障碍(PMDD)的女性在月经周期黄体晚期和卵泡期的情绪、认知表现及食欲变化。
Horm Behav. 2008 Jun;54(1):185-93. doi: 10.1016/j.yhbeh.2008.02.018. Epub 2008 Mar 7.
6
Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.经前烦躁障碍黄体期的抑郁情绪与额叶α波不对称性
J Obstet Gynaecol Res. 2013 May;39(5):998-1006. doi: 10.1111/jog.12020. Epub 2013 Apr 4.
7
Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects.经前烦躁障碍及正常对照受试者月经周期和睡眠剥夺期间的体温昼夜节律
J Biol Rhythms. 1997 Feb;12(1):34-46. doi: 10.1177/074873049701200106.
8
Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.在一项诊断访谈研究中,广泛性焦虑障碍与经前烦躁障碍之间的关联。
Int J Environ Res Public Health. 2020 Feb 5;17(3):988. doi: 10.3390/ijerph17030988.
9
Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.健康女性及经前烦躁障碍女性月经周期中皮质γ-氨基丁酸水平:一项质子磁共振波谱研究
Arch Gen Psychiatry. 2002 Sep;59(9):851-8. doi: 10.1001/archpsyc.59.9.851.
10
Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.经前期烦躁障碍患者情绪刺激下杏仁核反应性的月经周期变化。
Horm Behav. 2012 Sep;62(4):400-6. doi: 10.1016/j.yhbeh.2012.07.005. Epub 2012 Jul 17.

引用本文的文献

1
Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.有虐待史女性生物学特征的持续改变:经前烦躁障碍的影响
Health Psychol. 2007 Mar;26(2):201-13. doi: 10.1037/0278-6133.26.2.201.
2
Role of estrogen in the aetiology and treatment of mood disorders.雌激素在情绪障碍的病因学及治疗中的作用。
CNS Drugs. 2001;15(10):797-817. doi: 10.2165/00023210-200115100-00005.